Skip to main content

Day: June 26, 2024

Reliance Global Group Announces Reverse Stock Split

LAKEWOOD, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI; RELIW) (“Reliance”, “we” or the “Company”) today announced that the Company’s Board of Directors approved a 1-for-17 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock (the “Common Stock”) in order to regain compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (Rule 5550(a)(2)). The Company was not required to obtain shareholder approval to effectuate the Reverse Stock Split. The Company filed articles of amendment to the Company’s articles of incorporation, as amended, with the Secretary of State of the State of Florida to effectuate the Reverse Stock Split as of 5:00 p.m. Eastern Time on June 28, 2024. The Common Stock will begin trading on The Nasdaq Capital...

Continue reading

Goldenstone Acquisition Limited. and Infintium Fuel Cell Systems, Inc. Announce Definitive Business Combination Agreement

Infintium’s advanced hydrogen fuel cell technologies for material handling vehicles bring carbon-free and clean power source to major automotive, industrial, and retail companies Corporate net zero commitments expected to propel hydrogen powered heavy duty truck adoption Aurora, IL and Greer, SC, June 26, 2024 (GLOBE NEWSWIRE) — Goldenstone Acqusition Limited (“Goldenstone”), (NASDAQ: GDST), a Delaware blank check company, today announced that it and Infintium Fuel Cell Systems, Inc. (“Infintium” or the “Company”), a Greer, South Carolina based hydrogen fuel cell technology provider to some of the world’s largest commercial, industrial and retail companies, have entered into a definitive business combination agreement (the “Business Combination Agreement,” and the transactions contemplated thereunder, collectively, the “Business...

Continue reading

Texas Capital to Open Full-Service, Digital-Forward Financial Center in Southlake, Texas

DALLAS, June 26, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced it will open a new financial center in Southlake, Texas next month. It will be the first location of its kind for the firm, transforming its retail strategy to meet the evolving needs of the clients within the markets it serves across Texas. The Southlake Financial Center will be located at 1538 East Southlake Boulevard in the heart of the Southlake Town Square alongside State Highway 114. As part of Texas Capital’s firm-wide transformation, the new location will advance the firm’s commitment to delivering relationship-focused, elevated client experiences. The location was designed to complement digital capabilities with the in-person experience that provides access to the firm’s private wealth...

Continue reading

Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

Lengthens Patent Exclusivity of Plogosertib until August 2040 BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the receipt of a notice from the European Patent Office of the intention to grant a patent which includes claims to novel pharmaceutical compositions of plogosertib, a PLK1 inhibitor. Once granted, the European patent will provide exclusivity until August 2040 not including any extensions. The Company is prosecuting patent applications from the same family in other jurisdictions. “The notice further strengthens the Company’s patent portfolio and attests to the novelty of Cyclacel’s clinical...

Continue reading

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

DALLAS, June 26, 2024 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 14,361,113 shares of its common stock at a price to the public of $2.25 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18,972,221 shares of its common stock at an offering price of $2.249 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered...

Continue reading

Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety

Amplify Bio to complete GLP study of SPC-15 Novel Intranasal Therapeutic Silo study advances SPC-15 towards first-in-human trial SARASOTA, FL, June 26, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that it has awarded a contract to its contract research organization (CRO) partner AmplifyBio for an investigational new drug (IND)-enabling large animal GLP (Good Laboratory Practice) study of its lead asset, SPC-15, an intranasal prophylactic treatment for post-traumatic stress disorder (PTSD). The 4-week GLP study will evaluate a 28-day repeat intranasal dosing with a 14-day recovery. In a recent non-GLP small...

Continue reading

Caisse Française de Financement Local: EMTN 2024-3 Amended&Restated Final Terms

Paris, 26 June 2024 Caisse Française de Financement Local (“Caffil”) has amended the Final Terms dated 1 March 2024 relating to the issue of €20,000,000 3.812 per cent. obligations foncières due 5 March 2064 (ISIN Code: FR001400OGL4) (the “Obligations Foncières”) under its €75,000,000,000 EMTN Programme (the “Amended and Restated Final Terms”). The amendment provides for the correction of the following manifest error in the Final Terms: Item 21 (ii) entitled “Optional Redemption Amount of each Obligation Foncière” in Part A ofthe Final Terms is deleted and replaced as follows: (ii) Optional Redemption Amount of eachObligation Foncière: EUR 100,000 per Obligation Foncière of EUR 100,000 Specified Denomination Caffil accepts responsibility for the information included in this notice to the bondholders. The...

Continue reading

Nuwellis Announces Reverse Stock Split

MINNEAPOLIS, June 26, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, announced today a 1-for-35 reverse split (the “Reverse Stock Split”) of its common stock, par value $0.0001 (the “Common Stock”), effective at 5:00 pm Eastern Time June 27, 2024. Beginning on June 28, 2024, the Company’s Common Stock will trade on The Nasdaq Capital Market on a split-adjusted basis. At the Company’s annual meeting of stockholders on June 6, 2024, its stockholders approved a proposal to amend the Company’s Fourth Amended and Restated Certificate of Incorporation to effect such a reverse split of the Company’s outstanding Common Stock at a ratio in the range of 1-for-5 to 1-for-70 to be determined at the discretion...

Continue reading

Genius Group to Present at Noble Capital Markets Virtual Equity Conference on June 26, 2024

Singapore, June 26, 2024 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered education group, today announced that management has been invited to present at the Noble Capital Markets Virtual Equity Conference, being held June 26-27, 2024. Peter Ritz, Genius Group’s CRO, is scheduled to host virtual one-on-one meetings with institutional investors throughout the event, and will host a virtual presentation as follows: Noble Capital Markets Virtual Equity Conference Date: Wednesday, June 26, 2024 Time: 9:00 a.m. Eastern time Registration:https://www.meetmax.com/sched/event_107201/investor_reg_new.html?attendee_role_id=NOBLE_INVESTOR All interested investors are invited to join the online presentation. Please join at least ten minutes before...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.